MLN2704
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MLN2704, covering 2007-03-01 to 2007-07-13. Get the full timeline:
Most recent: Clinical Trial Update: MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer [Phase 1, Phase 2]